Results 111 to 120 of about 8,252,873 (160)

"When less is more and more is less" red cell alloimmunization in multitransfused patients attending a medical institution with a newly developed blood center in North India: A multifactorial study. [PDF]

Asian J Transfus Sci
Mukherjee R, Negi G, Kaur D, Nath UK, Chaturvedi Y, Bava D.   +5 more
europepmc   +1 more source

Red cell Alloimmunization and its Correlation with Clinical Spectrum & Transfusion Profile in Pediatric Thalassemia Major Patients: Experience from a Tertiary Care Pediatric Center in Northern India. [PDF]

Indian J Hematol Blood Transfus
Pradhan S, Behera BK, Prusty JBK, Satpathy S, Panda K.   +4 more
europepmc   +1 more source

Red cell alloimmunization & role of advanced immunohaematological support in liver transplantation. [PDF]

Indian J Med Res, 2017
Makroo RN, Agrawal S, Chowdhry M, Bhatia A, Thakur UK.   +4 more
europepmc   +1 more source

Red blood cell alloimmunization in myelodysplastic syndrome: a systematic review protocol

A systematic review protocol aiming to investigate the prevalence, specificity of alloantibodies, and associated risk factors for red blood cell alloimmunization in patients with myelodysplastic syndromes (MDS).
Marc Ferrís Adam
core  

Frequency and Risk Factors of Red Cell Alloimmunization in Transfused Patients with Sickle Cell Disease and Sickle Cell–β Thalassemia: A Three-Year Retrospective Study from a Tertiary Care Centre.

Current Clinical and Medical Education
Background: Red cell alloimmunization is a clinically significant complication of repeated transfusions in sickle haemoglobinopathies. Comparative data from eastern India remain limited.
Tenzing Yutchola Bhutia, Chumila Thinley Bhutia, Sonam Choden Bhutia   +2 more
doaj  

Type I interferon signature strength correlates with alloimmunization-associated transcriptomic programs in systemic lupus erythematosus: A multi-cohort analysis. [PDF]

PLoS One
Yoo J.
europepmc   +1 more source

Prevalence of Alloimmunization Among Patients With Transfusion-Dependent Thalassemia and Sickle Cell Disease in Salmaniya Medical Complex, Bahrain. [PDF]

Cureus
Altooq J, Sultan Z, Harb Z, Abdulla F, AlOmran M, Almeshal S.   +5 more
europepmc   +1 more source

Clinical Significance of Maternal Anti-D Antibody Titers in Severe RhD Alloimmunization Requiring Intrauterine Transfusion: A Tertiary Referral Center Experience. [PDF]

J Clin Med
Aykut S, Evrüke İC, Demir SC, Yalçın E, Kurt A, Nessar AZ.   +5 more
europepmc   +1 more source

Comparative analysis of low- and high-dose apheresis platelets in platelet-refractory patients with hematologic malignancies. [PDF]

Hematol Transfus Cell Ther
Rajendran S, Sharma RR, Hans R, Malhotra P, Lamba DS.   +4 more
europepmc   +1 more source

Cost analysis considerations for red blood cell matching to mitigate alloimmunization in patients with sickle cell disease. [PDF]

Transfusion
Adkins BD, Sarode R.
europepmc   +1 more source